EHMT2 and infection: To assess for any alteration in cell viability due to siRNA treatment in the infection scenario, we performed MTT assay at 48hpi with and without G9a or SIRT6 knockdown using specific siRNAs and did not observe any significant difference in cell viability (S2F Fig).